Use of an Algorithm for Administering Subcutaneous Heparin in the Treatment of Deep Venous Thrombosis

  1. Paolo Prandoni, MD, PhD;
  2. Paola Bagatella, MD;
  3. Enrico Bernardi, MD;
  4. Bruno Girolami, MD;
  5. Laura Rossi, MD;
  6. Luigi Scarano, MD;
  7. Antonio Marchiori, MD;
  8. Andrea Piccioli, MD; and
  9. Antonio Girolami, MD
  1. From the University of Padua Medical School, Padua, Italy Requests for Reprints: Paolo Prandoni, MD, PhD, Institute of Medical Semeiotics, University of Padua Medical School, via Ospedale Civile, 105, 35128 Padua, Italy. Current Author Addresses: Drs. Prandoni, Bagatella, Bernardi, B. Girolami, Rossi, Scarano, Marchiori, Piccioli, and A. Girolami: Institute of Medical Semeiotics, University of Padua Medical School, via Ospedale Civile, 105, 35128 Padua, Italy.

    Abstract

    Background: Despite the widespread use of subcutaneous heparin in the initial treatment of deep venous thrombosis, there are no guidelines for achieving adequate anticoagulation with this drug.

    Objective: To implement a weight-based algorithm for the administration of subcutaneous unfractionated heparin after an intravenous loading dose.

    Design: Prospective cohort study.

    Setting: University hospital.

    Participants: 70 outpatients with proximal venous thrombosis.

    Intervention: An intravenous bolus of heparin followed by a subcutaneous injection of heparin in doses adjusted for body weight. Subsequent adjustments of the subcutaneous heparin dose were scheduled twice daily according to the algorithm; the activated partial thromboplastin time (aPT) was measured in the mid-interval (target range, 50 to 90 seconds).

    Results: The therapeutic threshold aPT (≥ 50 seconds) was achieved in 61 patients (87%) within 24 hours and in 69 patients (99%) within 48 hours. In 7 patients (10%), a supratherapeutic aPT lasted more than 12 hours. No major bleeding episodes or cases of heparin-induced thrombocytopenia were seen. Three patients (4.3% [95% CI, 0.9% to 12.0%]) had recurrent thromboembolism during 3 months of follow-up.

    Conclusion: The administration of subcutaneous heparin according to a weight-based algorithm allows the rapid achievement of effective and safe anticoagulation in patients with deep venous thrombosis.

    « Previous | Next Article »Table of Contents